Notice on soliciting opinions on the standards of 8 pharmaceutical excipients to be included in the Chinese Pharmacopoeia, including triethanolamine

All relevant units:

According to the "Chinese Pharmacopoeia" preparation plan, our committee organized relevant units to formulate and revise some pharmaceutical excipients standards.

According to the "Chinese Pharmacopoeia" medicinal excipients selection principle (the medicinal excipients that have been used in domestic and foreign preparations and whose safety has been confirmed), the relevant pharmaceutical excipient manufacturers and users are invited to give feedback on the proposed new standards The following information: The company produces or uses the pharmaceutical excipients, when the pharmaceutical excipients have been applied to which domestically marketed preparations, and how safe are the excipients and preparations

Relevant pharmaceutical excipient manufacturers and users are invited to provide feedback on the proposed new and revised standards: whether the company believes that the draft standard is applicable to the production or use of pharmaceutical excipients, reasons for inapplicability, and whether there are other suggestions

All relevant associations are requested to publicize widely among their member units, and relevant companies are invited to give feedback in time, and submit relevant opinions and suggestions to our committee in writing before March 1, 2022, together with relevant instructions, experimental data and contact information

Contact: Chen Lei, Kang Xiaobo

Phone: 010-67079566, 67079620

Email: 475@chp.

Mailing address: Office of the National Pharmacopoeia Commission, Building 11, Fahua South Lane, Dongcheng District, Beijing

Post Code: 100061